1. Home
  2. ARDX vs EQBK Comparison

ARDX vs EQBK Comparison

Compare ARDX & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • EQBK
  • Stock Information
  • Founded
  • ARDX 2007
  • EQBK 2002
  • Country
  • ARDX United States
  • EQBK United States
  • Employees
  • ARDX N/A
  • EQBK N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • EQBK Major Banks
  • Sector
  • ARDX Health Care
  • EQBK Finance
  • Exchange
  • ARDX Nasdaq
  • EQBK Nasdaq
  • Market Cap
  • ARDX 882.9M
  • EQBK 773.5M
  • IPO Year
  • ARDX 2014
  • EQBK 2015
  • Fundamental
  • Price
  • ARDX $6.55
  • EQBK $40.25
  • Analyst Decision
  • ARDX Strong Buy
  • EQBK Buy
  • Analyst Count
  • ARDX 9
  • EQBK 6
  • Target Price
  • ARDX $10.50
  • EQBK $46.20
  • AVG Volume (30 Days)
  • ARDX 3.2M
  • EQBK 86.5K
  • Earning Date
  • ARDX 10-30-2025
  • EQBK 10-14-2025
  • Dividend Yield
  • ARDX N/A
  • EQBK 1.47%
  • EPS Growth
  • ARDX N/A
  • EQBK 532.31
  • EPS
  • ARDX N/A
  • EQBK 4.01
  • Revenue
  • ARDX $386,146,000.00
  • EQBK $227,628,000.00
  • Revenue This Year
  • ARDX $17.79
  • EQBK $19.34
  • Revenue Next Year
  • ARDX $27.82
  • EQBK $11.25
  • P/E Ratio
  • ARDX N/A
  • EQBK $10.20
  • Revenue Growth
  • ARDX 83.88
  • EQBK 48.83
  • 52 Week Low
  • ARDX $3.21
  • EQBK $34.11
  • 52 Week High
  • ARDX $7.18
  • EQBK $50.85
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 71.64
  • EQBK 46.72
  • Support Level
  • ARDX $6.47
  • EQBK $41.52
  • Resistance Level
  • ARDX $6.78
  • EQBK $42.31
  • Average True Range (ATR)
  • ARDX 0.19
  • EQBK 0.96
  • MACD
  • ARDX -0.05
  • EQBK -0.14
  • Stochastic Oscillator
  • ARDX 67.18
  • EQBK 17.96

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

Share on Social Networks: